Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
Open Access
- 13 August 2024
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 64 (4) , 107302
Abstract
No abstract availableKeywords
Funding Information
- Hjärt-Lungfonden (20150237)
- Hjärt-Lungfonden (20190229)
- Hjärt-Lungfonden (20220859)
- Hjärt-Lungfonden (20210407)
- Hjärt-Lungfonden (20190226)
- Vetenskapsrådet (987589)
- Vetenskapsrådet (2016-02043)
- Vetenskapsrådet (2018-1256)
This publication has 13 references indexed in Scilit:
- The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysisClinical Infectious Diseases, 2023
- Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis TreatmentClinical Infectious Diseases, 2022
- Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort studyJournal of Antimicrobial Chemotherapy, 2022
- Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysisThe Lancet Respiratory Medicine, 2020
- Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and PharmacodynamicsTherapeutic Drug Monitoring, 2020
- Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosisInternational Journal of Antimicrobial Agents, 2017
- Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysisAnnals of Clinical Microbiology and Antimicrobials, 2016
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant TuberculosisEBioMedicine, 2015
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaEuropean Respiratory Journal, 2014
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1996